PMID- 38400899
OWN - NLM
STAT- MEDLINE
DCOM- 20240327
LR  - 20240413
IS  - 1434-3916 (Electronic)
IS  - 0936-8051 (Print)
IS  - 0936-8051 (Linking)
VI  - 144
IP  - 4
DP  - 2024 Apr
TI  - Use of a fluoroscopy-based robotic-assisted total hip arthroplasty system 
      produced greater improvements in patient-reported outcomes at one year compared 
      to manual, fluoroscopic-assisted technique.
PG  - 1843-1850
LID - 10.1007/s00402-024-05230-8 [doi]
AB  - INTRODUCTION: The adoption of new technology should be supported by improvements 
      in patient-reported outcomes (PROMs). The purpose of this study was to assess the 
      one-year PROMs of patients who underwent total hip arthroplasty (THA) using a 
      novel, fluoroscopy-based, robotic-assisted (RA-THA) system when compared to a 
      manual, fluoroscopic-assisted technique (mTHA). MATERIALS AND METHODS: A review 
      of 91 consecutive mTHA and 85 consecutive RA-THA via a direct anterior approach 
      was conducted. All cases were performed by the same surgeon at the same 
      institution, for a pre-operative diagnosis of osteoarthritis, avascular necrosis, 
      or rheumatoid arthritis. Outcomes included one-year Veterans RAND-12 (VR-12) 
      Physical/Mental, Hip Disability and Osteoarthritis Outcome (HOOS) Pain/Physical 
      Function/Joint Replacement, and University of California Los Angeles (UCLA) 
      Activity scores, as well as the difference between pre-operative and one-year 
      post-operative PROMs. RESULTS: Patients in the RA-THA cohort had lower 
      pre-operative HOOS-JR scores compared to patients in the mTHA cohort (37.0 vs. 
      43.1; p = 0.031). Cohorts experienced similar one-year post-operative VR-12, 
      HOOS, and UCLA Activity scores. Patients in the RA-THA cohort experienced greater 
      improvements across all pre- and post-operative HOOS scores compared to patients 
      in the mTHA cohort: Pain (+ 54.7 vs. +42.1; p = 0.009), Physical Function (-41.6 
      vs. -28.7; p = 0.007), and Joint Replacement (+ 46.6 vs. +33.0; p = 0.002). These 
      differences exceeded minimum clinically important difference (MCID). CONCLUSIONS: 
      Both manual and robotic cohorts experienced benefit from THA at one-year 
      post-operative. Importantly, the use of a novel, fluoroscopy-based robotic 
      assistance system for primary THA resulted in greater improvements in PROMs at 
      one-year relative to manual technique.
CI  - (c) 2024. The Author(s).
FAU - Buchan, Graham B J
AU  - Buchan GBJ
AD  - Department of Orthopaedic Surgery, Orthopaedic and Rheumatologic Institute, 
      Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH, 44195, USA.
FAU - Ong, Christian B
AU  - Ong CB
AD  - Department of Orthopaedic Surgery, Orthopaedic and Rheumatologic Institute, 
      Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH, 44195, USA.
FAU - Hecht Ii, Christian J
AU  - Hecht Ii CJ
AD  - Department of Orthopaedic Surgery, Orthopaedic and Rheumatologic Institute, 
      Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH, 44195, USA.
FAU - DeCook, Charles A
AU  - DeCook CA
AD  - Arthritis and Total Joint Specialists, 2000 Howard Farm Drive, Suite 200, 
      Cumming, GA, 30041, USA.
FAU - Spencer-Gardner, Luke S
AU  - Spencer-Gardner LS
AD  - Department of Orthopaedic Surgery, Mayo Clinic, 4500 San Pablo Rd S, 
      Jacksonville, FL, 32224, USA.
FAU - Kamath, Atul F
AU  - Kamath AF
AD  - Department of Orthopaedic Surgery, Orthopaedic and Rheumatologic Institute, 
      Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH, 44195, USA. 
      kamatha@ccf.org.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20240224
PL  - Germany
TA  - Arch Orthop Trauma Surg
JT  - Archives of orthopaedic and trauma surgery
JID - 9011043
SB  - IM
MH  - Humans
MH  - *Arthroplasty, Replacement, Hip/methods
MH  - *Robotic Surgical Procedures/methods
MH  - Treatment Outcome
MH  - *Osteoarthritis
MH  - Patient Reported Outcome Measures
MH  - Pain
MH  - Fluoroscopy
PMC - PMC10965579
OTO - NOTNLM
OT  - Arthroplasty
OT  - Hip
OT  - Patient-reported outcome measures
OT  - Robotic-assisted surgery
COIS- * Authors G.B.J.B., C.B.O., C.J.H., and L.S.SG. declare that they have no 
      relevant competing interests. Authors C.A.D. and A.F.K. have the below 
      disclosures: *C.A.D.  *Royalties: DePuySynthes, Mizuho-OSI.  *Speakers bureau: 
      DePuySynthes, Medtronic.  *Stock or stock options: JointPoint, JointVue. *A.F.K. 
       *Royalties: Innomed, ZimmerBiomet.  *Speakers bureau: ZimmerBiomet, Johnson and 
      Johnson, BodyCad.  *Paid consultant: ZimmerBiomet, Johnson and Johnson, BodyCad, 
      United Ortho, Orthopedic Development.  *Stock or stock options: ZimmerBiomet, 
      Johnson and Johnson, Procter and Gamble.  *Research support: Signature 
      Orthopedics.
EDAT- 2024/02/24 21:43
MHDA- 2024/03/27 06:43
PMCR- 2024/02/24
CRDT- 2024/02/24 11:12
PHST- 2023/10/11 00:00 [received]
PHST- 2024/02/15 00:00 [accepted]
PHST- 2024/03/27 06:43 [medline]
PHST- 2024/02/24 21:43 [pubmed]
PHST- 2024/02/24 11:12 [entrez]
PHST- 2024/02/24 00:00 [pmc-release]
AID - 10.1007/s00402-024-05230-8 [pii]
AID - 5230 [pii]
AID - 10.1007/s00402-024-05230-8 [doi]
PST - ppublish
SO  - Arch Orthop Trauma Surg. 2024 Apr;144(4):1843-1850. doi: 
      10.1007/s00402-024-05230-8. Epub 2024 Feb 24.